Stocks360

Bionoid Pharma, Inc. (BINP)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS
$0.03

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$1.62M
PE (TTM)
-6.00
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-4.66
Day Range
$0.03 – $0.03
52-wk Range
$0.02 – $0.45
Avg Volume
N/A
Volume
1.00K

Bionoid Pharma, Inc. (BINP) is a publicly traded company in the Healthcare sector. Latest price: $0.03. Market cap $1.62M. Trailing PE -6.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $0.04 2025-12-29 · $0.03 (-20.42%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Bionoid Pharma, Inc.

Bionoid Pharma, Inc. functions as a medical technology enterprise. This company concentrates on the creation and commercialization of advanced medical instruments and solutions, primarily targeting the orthopedic and pain management industries. Founded on October 20, 1997, its corporate headquarters are situated in Beverly Hills, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-6.00×
P/S (TTM)0.00×
P/B-19.28×
PEG0.05×
P/FCF (TTM)7042.77×
EV / EBITDA3.19×
EV / Sales0.00×
Earnings Yield-19.57%
Free Cash Flow Yield0.01%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$1.77M
Net Income (TTM)-$317.00K
Free Cash Flow (TTM)$1.88K
Net Debt$152.19K
Working Capital-$102.67K
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity395.59%
Return on Invested Capital-390.40%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap